Two-dimensional electrophoretic analysis of membranous protein from human thyroid tissues and cancer cell lines

Citation
Jd. Lin et al., Two-dimensional electrophoretic analysis of membranous protein from human thyroid tissues and cancer cell lines, ELECTROPHOR, 19(18), 1998, pp. 3213-3216
Citations number
25
Categorie Soggetti
Chemistry & Analysis
Journal title
ELECTROPHORESIS
ISSN journal
01730835 → ACNP
Volume
19
Issue
18
Year of publication
1998
Pages
3213 - 3216
Database
ISI
SICI code
0173-0835(199812)19:18<3213:TEAOMP>2.0.ZU;2-K
Abstract
Thyroid neoplasm is the most commonly encountered neoplastic disorder in en docrine clinics. Thyroid scan, ultrasonography, and fine needle aspiration cytology (FNAC) are used as diagnostic tools to differentiate a malignant n odule from a benign lesion. There are certain limitations and pitfalls in F NAC, especially in the diagnosing of follicular tumors. The lack of charact eristic findings or a specific tumor marker are the most common problems in the preoperative diagnosis of thyroid follicular carcinoma. Although serum thyroglobulin level has been used as a tumor marker for post-operative, we ll-differentiated thyroid cancer, the assay cannot be used for preoperative diagnosis of thyroid carcinoma. In this study, various thyroid tissues and cancer cell lines including CGTH W-1, CGTH W-3, RO 82 W-1, SW 579 cell lin es were used for the investigation of tumor markers. Specific spots were id entified in the area near the 60 kDa molecular mass protein and isoelectric point (pI) 5.9 of the CGTH W-1 cell line. These spots could not be found i n the papillary or anaplastic thyroid cancer cell lines. Another spot with a molecular weight of about 9.8 kDa with a low pI of 4.8 was present in the CGTH W-1 and RO 82 W-1 cell lines. This spot appeared to be a tumor marker of follicular cancer cells. This spot could not be found in the papillary and anaplastic cancer cell lines and other benign thyroid tissues. Specific proteins that were identified in this study may be useful as tumor markers for follicular thyroid carcinoma.